Project Grant R01DK147509
- Federal Project Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $639,838 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded December 15, 2025, with completion anticipated by November 30, 2030. The research focuses on investigating the role of amyloid precursor protein (APP) metabolites in extracellular vesicle (EV) cargo and function as they relate to Alzheimer's disease pathogenesis. The project will...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $574,757 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 13, 2026, with a completion date of January 31, 2031. The award funds basic biomedical research investigating the mechanisms by which estrogen deficiency induces...
- Federal Grant Award Summary Rutgers, The State University of New Jersey (RBHS-School of Nursing) received a $816,524 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026 through January 31, 2031. The award supports comprehensive research investigating the mechanistic relationship between intestinal Clostridium bacterial communities...
- Federal Grant Award Summary Rutgers, The State University received a $175,928 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on February 6, 2026, with completion targeted for August 5, 2027. The award funds investigator-initiated research focused on elucidating the role of EPHB2 receptor tyrosine kinase signaling in intestinal epithelial...
- Federal Project Grant Award Summary Award Overview Indiana University Indianapolis received a $811,217 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 18, 2026, with completion targeted for January 31, 2031. The award supports fundamental research on signaling mechanisms of ultra-stable single-chain insulin (SCI) analogs and...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $431,750 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with a completion date of January 31, 2028. The award supports investigator-initiated biomedical research examining the mechanisms by which interferon-gamma (IFN-γ) regulates appetite...
- Federal Project Grant Award Summary New York University received a $1.94M Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 19, 2025, through August 31, 2028. The award funds research to develop and evaluate an Adaptive Dietary Intervention (ADI) leveraging Continuous Glucose Monitoring (CGM) technology for Asian Americans with Type...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $235,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of September 14, 2027. The award funds research to investigate gut microbial functions that impact Crohn's disease (CD) risk,...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Indiana University Indianapolis a $6.19 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 1, 2025, through August 31, 2029. This four-year research initiative investigates the relationship between depression treatment and diabetes risk reduction in people with HIV (PWH) on antiretroviral...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
Rutgers, The State University received a $314,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2026, through May 31, 2029. The award funds a pilot randomized controlled trial investigating the combined efficacy of intranasal insulin (INI) therapy and aerobic exercise (AEX) training on cerebrovascular function, brain insulin signaling, and cognitive outcomes in older adults (ages 55-80) with type 2 diabetes at high risk for Alzheimer's disease and related dementias (ADRD). The research will evaluate measures of cerebral blood flow, blood-brain barrier integrity, and neuronal insulin signaling pathways, with the hypothesis that INI combined with AEX will produce superior improvements in brain vascular function and cognitive performance compared to exercise alone with placebo treatment. The study delivers research services including a 16-week clinical intervention protocol, vascular and metabolic assessments, molecular analysis of neuronal extracellular vesicles for insulin signaling biomarkers, and cognitive outcome measurements. Research activities are conducted at Rutgers' Piscataway, New Jersey facility. This pilot investigation aims to establish mechanistic understanding of brain insulin responses and identify novel therapeutic targets for metabolic disease progression, with potential to inform clinical approaches for preventing cognitive decline in individuals with type 2 diabetes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $314.0k | 5/15/26 |